Pre-clinical assessment of EpCAM as a target for antibody based therapies of gastric cancer

被引：0
|
作者：
Kobold, S. [1 ]
Henkel, J. [1 ]
Steffen, J. [1 ]
Grassmann, J. [1 ]
Zimmermann, W. [2 ]
Bourquin, C. [1 ]
Endres, S. [1 ]
机构：
[1] Univ Munich, Div Clin Pharmacol, Ctr Integrated Prot Sci Munich CIPS M, Dept Med Ludwig 4, Munich, Germany
[2] Univ Munich, LIFE Ctr, Tumor Immunol Lab, Munich, Germany
来源：
IMMUNOLOGY | 2012年 / 137卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：721 / 721
页数：1
相关论文
共 50 条
  • [21] PRE-CLINICAL STUDIES FOR ADVANCING CIRMTUZUMAB-BASED ANTI-ROR1 THERAPIES IN METASTATIC PROSTATE CANCER
    Muldong, Michelle
    Lee, Sanghee
    Mendoza, Theresa
    Burner, Danielle
    Wu, Christina
    Murtadha, Jamillah
    Koutouan, Evodie
    Pineda, Naomi
    Pineda, Gabriel
    Lennon, Kathleen
    Hao Pham
    Willert, Karl
    Cacalano, Nicholas
    Jamieson, Catriona
    Gaasterland, Terry
    Kane, Christopher
    Kulidjian, Anna
    Jamieson, Christina
    JOURNAL OF UROLOGY, 2022, 207 (05): : E99 - E99
  • [22] Renal Effects of Incretin-Based Diabetes Therapies: Pre-clinical Predictions and Clinical Trial Outcomes
    Scott C. Thomson
    Volker Vallon
    Current Diabetes Reports, 2018, 18
  • [23] Renal Effects of Incretin-Based Diabetes Therapies: Pre-clinical Predictions and Clinical Trial Outcomes
    Thomson, Scott C.
    Vallon, Volker
    CURRENT DIABETES REPORTS, 2018, 18 (05)
  • [24] Pre-clinical assessment of autologous DC-based therapy in ovarian cancer patients with progressive disease
    Hardwick, Nicola
    Ledermann, Jonathan A.
    Aitkens, Egla
    Chain, Benny
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (11) : 1929 - 1939
  • [25] Pre-clinical assessment of autologous DC-based therapy in ovarian cancer patients with progressive disease
    Nicola Hardwick
    Jonathan A. Ledermann
    Egla Aitkens
    Benny Chain
    Cancer Immunology, Immunotherapy, 2012, 61 : 1929 - 1939
  • [26] THYMIDINE PHOSPHORYLASE OVEREXPRESSION IN ORAL CANCER TISSUE AS A TARGET OF CAPECITABINE: THE PRE-CLINICAL RATIONAL
    Ranieri, G.
    Patruno, R.
    Saponaro, G.
    Console, G.
    Paradiso, A.
    Grammatica, L.
    ANNALS OF ONCOLOGY, 2004, 15 : 47 - 47
  • [27] Pre-clinical evaluation of Claudin 18.2 TAC T cells for the treatment of gastric cancer
    Benatar, Tania
    Wang, Ling
    Nitya-Nootan, Thanyashanthi
    MacGregor, Heather
    Prosser, Suzanna
    Ip, Philbert
    Lal, Prabha
    Shaver, Laura
    Sengupta, Sadhak
    Helsen, Christopher W.
    Bader, Andreas G.
    CANCER RESEARCH, 2022, 82 (12)
  • [28] Choosing the Optimal Brain Target for Neuromodulation Therapies as Alcohol Addiction Progresses—Insights From Pre-Clinical Studies
    Henriette Edemann-Callesen
    Segev Barak
    Ravit Hadar
    Christine Winter
    Current Addiction Reports, 2020, 7 : 237 - 244
  • [29] Relevance of IGF signaling pathway in human hepatocellular carcinoma, and pre-clinical assessment of novel targeted therapies
    Tovar, Victoria
    Alsinet, Clara
    Sole, Manel
    Villanueva, Augusto
    Chiang, Derek
    Cabellos, Laia
    Lazaro, Adriana
    Schwartz, Myron
    Mazzaferro, Vincenzo
    Bruix, Jordi
    Llovet, Josep M.
    HEPATOLOGY, 2007, 46 (04) : 520A - 520A
  • [30] Angiogenesis in Pancreatic Cancer: Pre-Clinical and Clinical Studies
    Annese, Tiziana
    Tamma, Roberto
    Ruggieri, Simona
    Ribatti, Domenico
    CANCERS, 2019, 11 (03)
12345